BiotechTube
Home/StrideBio/Patricia Zilliox, Ph.D.
PZ

Patricia Zilliox, Ph.D.

Chief Development Officer

StrideBio

Therapeutic Areas

NeurologyCardiovascularMetabolicGenetic Disorders

StrideBio Pipeline

DrugIndicationPhase
STRX-110SLC13A5 Deficiency (pediatric epilepsy)Phase 1/2
Friedreich's Ataxia ProgramFriedreich's AtaxiaPreclinical
Cardiovascular ProgramUndisclosed Genetic Cardiovascular DiseasePreclinical

Leadership Team at StrideBio

SS
Sapan Shah, Ph.D.
Chief Executive Officer
AA
Aravind Asokan, Ph.D.
Founder & Chief Scientific Advisor
CD
Cynthia Dunbar, M.D.
Chief Medical Officer
View full StrideBio profile